Equities research analysts forecast that Mettler-Toledo International Inc. (NYSE:MTD) will report earnings of $5.09 per share for the current fiscal quarter, according to Zacks. Five analysts have provided estimates for Mettler-Toledo International’s earnings, with the highest EPS estimate coming in at $5.10 and the lowest estimate coming in at $5.07. Mettler-Toledo International posted earnings of $4.65 per share during the same quarter last year, which suggests a positive year over year growth rate of 9.5%. The company is expected to report its next quarterly earnings results on Thursday, July 25th.
According to Zacks, analysts expect that Mettler-Toledo International will report full-year earnings of $22.70 per share for the current fiscal year, with EPS estimates ranging from $22.65 to $22.75. For the next financial year, analysts expect that the business will report earnings of $25.32 per share, with EPS estimates ranging from $25.20 to $25.55. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side analysts that that provide coverage for Mettler-Toledo International.
Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, May 9th. The medical instruments supplier reported $4.10 EPS for the quarter, topping the consensus estimate of $4.06 by $0.04. Mettler-Toledo International had a net margin of 17.98% and a return on equity of 95.67%. The business had revenue of $679.50 million for the quarter, compared to analyst estimates of $673.55 million. During the same period in the previous year, the firm earned $3.74 EPS. The business’s revenue for the quarter was up 2.8% compared to the same quarter last year.
Mettler-Toledo International stock opened at $825.97 on Wednesday. Mettler-Toledo International has a 52 week low of $500.74 and a 52 week high of $839.61. The company has a quick ratio of 0.97, a current ratio of 1.37 and a debt-to-equity ratio of 1.80. The stock has a 50-day simple moving average of $758.94. The stock has a market cap of $20.49 billion, a price-to-earnings ratio of 40.65, a PEG ratio of 2.66 and a beta of 1.28.
In other news, CFO Shawn Vadala sold 700 shares of the stock in a transaction dated Tuesday, May 14th. The shares were sold at an average price of $721.00, for a total transaction of $504,700.00. Following the transaction, the chief financial officer now directly owns 5,450 shares in the company, valued at approximately $3,929,450. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Wah-Hui Chu sold 300 shares of the stock in a transaction dated Friday, May 17th. The stock was sold at an average price of $740.00, for a total transaction of $222,000.00. Following the transaction, the director now owns 3,154 shares in the company, valued at $2,333,960. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 48,925 shares of company stock worth $35,650,928. Insiders own 3.50% of the company’s stock.
Several hedge funds have recently made changes to their positions in the company. CIBC Private Wealth Group LLC lifted its holdings in shares of Mettler-Toledo International by 3.3% during the 1st quarter. CIBC Private Wealth Group LLC now owns 470 shares of the medical instruments supplier’s stock worth $340,000 after acquiring an additional 15 shares during the period. Thrivent Financial for Lutherans lifted its holdings in shares of Mettler-Toledo International by 1.7% during the 4th quarter. Thrivent Financial for Lutherans now owns 1,108 shares of the medical instruments supplier’s stock worth $627,000 after acquiring an additional 19 shares during the period. Commonwealth Bank of Australia lifted its holdings in shares of Mettler-Toledo International by 9.1% during the 1st quarter. Commonwealth Bank of Australia now owns 253 shares of the medical instruments supplier’s stock worth $181,000 after acquiring an additional 21 shares during the period. Eukles Asset Management lifted its holdings in shares of Mettler-Toledo International by 2.8% during the 1st quarter. Eukles Asset Management now owns 795 shares of the medical instruments supplier’s stock worth $575,000 after acquiring an additional 22 shares during the period. Finally, Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Mettler-Toledo International by 40.7% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 76 shares of the medical instruments supplier’s stock worth $55,000 after acquiring an additional 22 shares during the period. Institutional investors and hedge funds own 95.38% of the company’s stock.
Mettler-Toledo International Company Profile
Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; metal detection and other end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries; and solutions that are used in various process analytics applications.
Read More: Blockchain
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.